Navigation Links
Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine
Date:10/9/2008

CAMBRIDGE, Mass., Oct. 9 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced it has been named among the best biopharmaceutical companies in the world, according to Science magazine's annual survey of Top Employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries. With a 2008 ranking of eighth, the Company is in the top ten for the first time, moving up from a 2007 ranking of 14.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080827/NEW076LOGO )

"This top ten ranking underscores Millennium's commitment not only to breakthrough science, but also to its employees and overall working environment," said Stephen Gansler, Senior Vice President, Human Resources, Millennium. "It is now more important than ever for us to keep up this positive work culture as we recruit for the hundreds of new additions over the next few months."

Respondents to the web-based survey were asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change and a research-driven environment. The 2008 survey sought to identify the companies with the best reputations as employers, based on nearly 4,000 survey responses from readers of Science and other respondents in industry. Twenty percent of the respondents came from outside the United States, primarily Western Europe, and 92 percent worked in private industry. For the complete business office feature with individual company rankings, please visit: http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articl es/ 2008_10_10/science.opms.r0800061.

Millennium was acquired by Takeda Pharmaceutical Company Limited in May, 2008.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical co
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
2. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
3. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
4. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
5. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
6. Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
7. Millennium Announces $200,000 Purchase Order From Greek Distributor
8. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
9. Millennium Over-Delivers on 2007 Goals and Financial Guidance
10. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
11. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Researchers from the ... connection between lower back pain, and the acne causing P.acnes ... the system the bacteria seek out oxygen deprived location to ... the spinal column, P.acnes has the ability to live in ... Fernando Perez, a spokesman for “ The best acne treatment ...
(Date:5/20/2013)... Culver City, CA (PRWEB) May 20, 2013 ... Trustees has announced the appointment of Lisa Baird as ... WMIS on July 8, 2013. The WMIS ... multi-modal imaging applications to understand and effectively treat diseases ... Molecular Imaging Society (WMIS) was established in 2011 by ...
(Date:5/17/2013)... 2013 Oven Industries Inc. announces a ... temperature controller has many user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... be used universally, which allows the user to use ...
(Date:5/17/2013)... PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability ,     New ... insect pressures , Syngenta unveiled ... celebration today at the company’s RTP Innovation Center. The ... allows company researchers to simulate any agricultural climate and ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2New Temperature Control Products Announced by Oven Industries Inc. 2Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC Bulletin ... developer and distributor of plant and animal ... today announced that it closed a private ... which included,many of the same investors who ...
... million, up 9% from $31.0 million in Q1,08 , - ... Q1,08 , - Gross Margin: 21%, up from 13% in ... plcLAWRENCE, Mass., May 8 NxStage Medical, Inc. (Nasdaq: ... today announced net revenue for the first quarter of 2009 ...
... Scheduled Today at 4:30pm ET European ... Company to Provide Update on FDA review ... Corporate Highlights: - CHMP issued positive opinion ... peripheral neuropathic pain in non-diabetic adults, either alone or ...
Cached Biology Technology:Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance 2Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance 3NxStage Reports First Quarter 2009 Financial Results 2NxStage Reports First Quarter 2009 Financial Results 3NxStage Reports First Quarter 2009 Financial Results 4NxStage Reports First Quarter 2009 Financial Results 5NxStage Reports First Quarter 2009 Financial Results 6NxStage Reports First Quarter 2009 Financial Results 7NxStage Reports First Quarter 2009 Financial Results 8NxStage Reports First Quarter 2009 Financial Results 9NxStage Reports First Quarter 2009 Financial Results 10NxStage Reports First Quarter 2009 Financial Results 11NeurogesX Reports First Quarter 2009 Results 2NeurogesX Reports First Quarter 2009 Results 3NeurogesX Reports First Quarter 2009 Results 4NeurogesX Reports First Quarter 2009 Results 5NeurogesX Reports First Quarter 2009 Results 6NeurogesX Reports First Quarter 2009 Results 7NeurogesX Reports First Quarter 2009 Results 8NeurogesX Reports First Quarter 2009 Results 9NeurogesX Reports First Quarter 2009 Results 10NeurogesX Reports First Quarter 2009 Results 11
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... (SDB) 72nd Annual Meeting in Cancun, Mexico from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... layer lining the body,s blood vessels, is extremely ... thickness, this super-tenuous structure routinely withstands blood flow, ... a unique and highly dynamic barrier that maintains ... body,s circulatory system. , It,s also extremely adaptable. ... breached to enable immune cells to reach ...
(Date:5/16/2013)... about 23 million years old give unprecedented insight ... one of the most species-rich groups among the ... Professor Bettina Reichenbacher from the Division of Paleontology ... Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / ... fossils which they assign to the group of ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
... PHILADELPHIA and REHOVOT, Israel, Oct. 19, 2011 Rosetta ... leading developer and provider of microRNA-based molecular diagnostics, today ... previously announced private placement and expects to receive $1.5 ... an aggregate of 2,025,001 ordinary shares at a price ...
... Oct. 19, 2011 The intestinal ecosystem is ... studies by UT Southwestern Medical Center researchers published in ... together, these studies provide a new understanding of the ... prevention of inflammatory bowel disease (IBD) and viral infections, ...
... university scientists reports a breakthrough in the development of ... The results of their study, "A Neutralizing Human Monoclonal ... will appear in Science Translational Medicine online. ... of the embargo at 2 p.m. Oct. 19, 2011. ...
Cached Biology News:Rosetta Genomics Initiates Closing of Private Placement 2UT Southwestern research could lead to new treatments for IBD, viral infections 2UT Southwestern research could lead to new treatments for IBD, viral infections 3Scientists report major advance in human antibody therapy against deadly Hendra virus 2Scientists report major advance in human antibody therapy against deadly Hendra virus 3Scientists report major advance in human antibody therapy against deadly Hendra virus 4
Monoclonal antibodies conjugated with rhodamine...
... the Moticam 2300 camera (MC2300) attaches to ... or trinocular port. Included in the standard ... 2.0ML software offers quick and accurate image ... resolution for examination or documentation purposes. The ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... StabilZyme NOBLE BSA-Free Stabilizer is ... SELECT Stabilizer. It is an ... chemicals in a MOPS buffer (3-(N-Morpholino) ... and contains a combination of 0.02% ...
Biology Products: